Jabra Enhance Plus vs Otofonix Groove

The Jabra Enhance Plus is a mid-priced OTC hearing aid ($799) that earns a B grade with a SoundScore of 3.8/5 in our lab testing, ranking #28 of 65 devices in the OTC category. This visible-in-ear device delivers strong speech-in-quiet performance, scoring 4.2/5—a full 1.36 points above the category average. Music streaming is another highlight at 3.8/5, nearly 1.9 points above average, making it a solid choice for users who value audio quality beyond speech. Speech-in-noise performance scores 2.1/5, which is above the category average by 0.62 points but remains mixed in absolute terms for challenging listening environments. The most significant limitation is own-voice comfort, scoring just 0.3/5—well below the category average of 2.51/5. Users sensitive to how their own voice sounds while wearing hearing aids should consider this trade-off carefully. Feedback handling is excellent at 4.7/5, meaning wearers can expect stable performance without whistling or squealing. The Jabra Enhance Plus is best suited for users who prioritize clear speech in quieter settings and enjoy streaming music or calls to their iPhone. Those frequently in noisy environments or particularly bothered by occlusion effects may want to explore alternatives. Several competitors in the same price range achieve higher overall scores, including the Sony CRE-E10 and Lexie B2 Plus.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.